A--75N94026R00008_Pre-Solicitation_Notice_BPCA_DCC
National Institutes of Health · NATIONAL INSTITUTES OF HEALTH NICHD
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 75N94026R00008 in this department, oldest first.
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Answer the notice: this is when the requirement can still be shaped.
- Contact the contracting officer named on the notice.
- Check who won similar work; they are the likely bidders.
What the notice says
Data Coordinating Center (DCC) to provide clinical data management, statistical analysis, regulatory support, and data quality oversight for pediatric clinical trials conducted under the BPCA program to support FDA regulatory submissions and pediatric drug development research.
Who won similar work
50 award notices on SAM.gov in the last 24 months. Matched by: Same agency (National Institutes of Health), same product/service code (PSC) AN12.
Single-winner award sizes (31): middle half $8.3M to $48.0M, median $25.4M; range $10K to $100.0M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| FISHER BIOSERVICES INC · $TMO · $42.9B | 2 | $148.0M | Oct 7, 2026 |
| SIA PARTNERS U.S., INC. | 2 | $48.0M + 1 shared | Oct 7, 2026 |
| EMINENT SERVICES CORP | 2 | $32.9M + 1 shared | Jul 8, 2026 |
| Northwestern University 750 N. LAKE SHORE DRIVE RUBLOFF 7TH FLOOR CHICAGO IL 60611 USA | 2 | $7.7M + 1 shared | Apr 10, 2025 |
| WAKE FOREST UNIVERSITY HEALTH SCIENCES MEDICAL CENTER BLVD. Winston Salem NC 27157 USA | 2 | $4.9M + 1 shared | Apr 10, 2025 |
| UNIVERSITY OF MISSISSIPPI MEDICAL CENTER Jackson MS 39216 USA | 1 | $63.9M | Sep 15, 2025 |
| TEMPUS AI, INC · $TEM · $531.8M | 1 | $60.6M | Sep 17, 2025 |
| UNIVERSITY OF WASHINGTON 4333 BROOKLYN AVENUE NE BOX 359472 Seattle WA 98195 USA | 1 | $55.5M | Apr 10, 2025 |
| WAKE FOREST UNIVERSITY HEALTH SCIENCES Winston Salem NC 27157 USA | 1 | $49.5M | Sep 15, 2025 |
| Coriell Institute for Medical Research, Inc. | 1 | $48.3M | Aug 1, 2025 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- $TMO reported $42.9B revenue in FY2025. The median single-winner award in these 31 past awards, $25.4M, is under 0.1% of that. 10-K
- $TEM reported $531.8M revenue in FY2025. The median single-winner award in these 31 past awards, $25.4M, is 5% of that. 10-K
One award's total value against one year of revenue; many awards are paid over several years.
- Oct 7, 2026ADVANCED BIOSCIENCE LABORATORIES, INC.$48.0MVACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASESNo listed company matched (Materiality N/A)
- Oct 7, 2026BCG FEDERAL CORP.$48.0MVACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASESNo listed company matched (Materiality N/A)
- Oct 7, 2026SIA PARTNERS U.S., INC.$48.0MVACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASESNo listed company matched (Materiality N/A)
- Oct 7, 2026FISHER BIOSERVICES INC$48.0MVACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASESMateriality: 0.11% of $TMO revenue (Low) SEC
- Oct 7, 2026PPD DEVELOPMENT LP$48.0MVACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASESNo listed company matched (Materiality N/A)
- Oct 7, 2026AMERICAN TYPE CULTURE COLLECTION Manassas VA 20110 USA$48.0MVACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASESNo listed company matched (Materiality N/A)
- Aug 17, 2026TCG GREENCHEM INC$49.7M (shared ceiling)Chemistry, Manufacturing and Controls and Related Services for Development of Drug SubstancesShared multiple-award ceiling, not one company's win (Materiality N/A)
- Aug 5, 2026SIA PARTNERS U.S., INC.$49.7M (shared ceiling)Chemistry, Manufacturing and Controls and Related Services for Development of Drug SubstancesShared multiple-award ceiling, not one company's win (Materiality N/A)
- Aug 5, 2026ALCHEM LABORATORIES CORPORATION$49.7M (shared ceiling)Chemistry, Manufacturing and Controls and Related Services for Development of Drug SubstancesShared multiple-award ceiling, not one company's win (Materiality N/A)
- Aug 5, 2026TCG INC$49.7M (shared ceiling)Chemistry, Manufacturing and Controls and Related Services for Development of Drug SubstancesShared multiple-award ceiling, not one company's win (Materiality N/A)
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 1 of these past winners lobbied Natl Institutes of Health (NIH) since 2024 (7 filings)
- 0 of their lobbyists list a past Natl Institutes of Health (NIH) job
- $64K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Energy and Commerce, Senate Committee on Appropriations, Senate Committee on Health, Education, Labor, and Pensions
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 8 bills named on the past winners' lobbying filings
- 0 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 2 of the past winners are listed companies
- 0 insider buys and 28 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.